Current role
Sanjay Nayak
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Sanjay Nayak
Ocular Therapeutix, Inc reported in an 8-K filed February 22, 2024 that Sanjay Nayak was appointed Chief Strategy Officer, effective February 21, 2024.
“On February 21, 2024, the Company entered into an employment agreement with Sanjay Nayak, MBBS, Ph.D., providing for Dr. Nayak to serve as Chief Strategy Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Ocular Therapeutix, Inc (OCUL)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ocular Therapeutix, Inc
Other people whose current roles at this company are on record from its filings.
- Pravin Dugel CEO
- Pravin U. Dugel CEO, Chairman, Board Member
- Pravin U. Dugel, M.D. CEO, Chairman
- Charles Warden Chairman, Board Member
- Jason Robins CFO
- Donald Notman COO
- Philip C. Strassburger General Counsel
- Adrienne L. Graves Board Member
- Adrienne L. Graves, Ph.D. Board Member
- Jeffrey Heier Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.